ECSP10010183A - Producto de dispersión sólida de drogas basadas en n-aril-urea - Google Patents
Producto de dispersión sólida de drogas basadas en n-aril-ureaInfo
- Publication number
- ECSP10010183A ECSP10010183A EC2010010183A ECSP10010183A ECSP10010183A EC SP10010183 A ECSP10010183 A EC SP10010183A EC 2010010183 A EC2010010183 A EC 2010010183A EC SP10010183 A ECSP10010183 A EC SP10010183A EC SP10010183 A ECSP10010183 A EC SP10010183A
- Authority
- EC
- Ecuador
- Prior art keywords
- solid dispersion
- urea
- aril
- dispersion product
- based drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un producto que comprende al menos un agente con actividad farmacéutica basado en N-aril urea que se obtiene mediante a) la preparación de una mezcla líquida que contiene al menos un agente activo, al menos un agente formador de matriz farmacéuticamente aceptable, al menos un agente tensioactivo farmacéuticamente aceptable y al menos un solvente, y b) la eliminación de los uno o más solventes de la mezcla líquida, para obtener el producto de dispersión sólida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99961807P | 2007-10-19 | 2007-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP10010183A true ECSP10010183A (es) | 2010-06-29 |
Family
ID=40089463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2010010183A ECSP10010183A (es) | 2007-10-19 | 2010-05-17 | Producto de dispersión sólida de drogas basadas en n-aril-urea |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2197425A2 (es) |
JP (1) | JP2011500649A (es) |
KR (1) | KR20100087170A (es) |
CN (1) | CN101827584A (es) |
AU (1) | AU2008313622A1 (es) |
BR (1) | BRPI0818340A2 (es) |
CA (1) | CA2699301A1 (es) |
CO (1) | CO6270206A2 (es) |
CR (1) | CR11442A (es) |
DO (1) | DOP2010000117A (es) |
EC (1) | ECSP10010183A (es) |
GT (1) | GT201000102A (es) |
MX (1) | MX2010004291A (es) |
PA (1) | PA8800101A1 (es) |
RU (1) | RU2010119929A (es) |
UA (1) | UA100865C2 (es) |
WO (1) | WO2009050291A2 (es) |
ZA (1) | ZA201002095B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009100176A2 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
AR077975A1 (es) | 2009-08-28 | 2011-10-05 | Irm Llc | Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina |
MX2012014387A (es) * | 2010-06-09 | 2013-05-01 | Abbvie Inc | Dispersiones solidas que contienen inhibidores de cinasa. |
CA2855243C (en) | 2011-11-11 | 2020-04-14 | Novartis Ag | Method of treating a proliferative disease |
LT2782557T (lt) * | 2011-11-23 | 2018-12-27 | Array Biopharma, Inc. | Farmacinės kompozicijos |
WO2014003677A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising solid dispersion particles containing tadalafil |
WO2014003678A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070104780A1 (en) * | 2005-10-25 | 2007-05-10 | Lipari John M | Formulation comprising a drug of low water solubility and method of use thereof |
WO2007066189A2 (en) * | 2005-12-09 | 2007-06-14 | Pfizer Products Inc. | Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
EP2089003A1 (en) * | 2006-11-09 | 2009-08-19 | Abbott GmbH & Co. KG | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
-
2008
- 2008-10-17 MX MX2010004291A patent/MX2010004291A/es not_active Application Discontinuation
- 2008-10-17 WO PCT/EP2008/064076 patent/WO2009050291A2/en active Application Filing
- 2008-10-17 AU AU2008313622A patent/AU2008313622A1/en not_active Abandoned
- 2008-10-17 CA CA2699301A patent/CA2699301A1/en not_active Abandoned
- 2008-10-17 KR KR1020107010979A patent/KR20100087170A/ko not_active Application Discontinuation
- 2008-10-17 RU RU2010119929/15A patent/RU2010119929A/ru not_active Application Discontinuation
- 2008-10-17 CN CN200880112150A patent/CN101827584A/zh active Pending
- 2008-10-17 UA UAA201006029A patent/UA100865C2/ru unknown
- 2008-10-17 PA PA20088800101A patent/PA8800101A1/es unknown
- 2008-10-17 EP EP08839333A patent/EP2197425A2/en not_active Withdrawn
- 2008-10-17 BR BRPI0818340 patent/BRPI0818340A2/pt not_active IP Right Cessation
- 2008-10-17 JP JP2010529408A patent/JP2011500649A/ja active Pending
-
2010
- 2010-03-24 ZA ZA2010/02095A patent/ZA201002095B/en unknown
- 2010-04-16 GT GT201000102A patent/GT201000102A/es unknown
- 2010-04-16 DO DO2010000117A patent/DOP2010000117A/es unknown
- 2010-04-27 CO CO10049271A patent/CO6270206A2/es not_active Application Discontinuation
- 2010-05-17 EC EC2010010183A patent/ECSP10010183A/es unknown
- 2010-05-19 CR CR11442A patent/CR11442A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DOP2010000117A (es) | 2010-05-15 |
WO2009050291A2 (en) | 2009-04-23 |
BRPI0818340A2 (pt) | 2015-04-22 |
UA100865C2 (ru) | 2013-02-11 |
ZA201002095B (en) | 2011-11-30 |
CA2699301A1 (en) | 2009-04-23 |
PA8800101A1 (es) | 2009-05-15 |
JP2011500649A (ja) | 2011-01-06 |
EP2197425A2 (en) | 2010-06-23 |
CO6270206A2 (es) | 2011-04-20 |
CR11442A (es) | 2010-09-06 |
CN101827584A (zh) | 2010-09-08 |
WO2009050291A3 (en) | 2010-04-08 |
RU2010119929A (ru) | 2011-11-27 |
AU2008313622A1 (en) | 2009-04-23 |
KR20100087170A (ko) | 2010-08-03 |
MX2010004291A (es) | 2010-08-02 |
GT201000102A (es) | 2012-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP10010184A (es) | Producto de dispersión sólida que contiene un compuesto a base de n-aril-urea | |
ECSP10010183A (es) | Producto de dispersión sólida de drogas basadas en n-aril-urea | |
AR059350A1 (es) | Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva | |
AR055561A1 (es) | Comprimidos con dispersion mejorada de la sustancia farmacologica | |
CO6470799A2 (es) | Composición farmacéutica oral auto-microemulsificante de un farmaco hidrofílico y método de preparación de ésta | |
CL2007003356A1 (es) | Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades. | |
WO2010041141A3 (en) | Oil-based foamable carriers and formulations | |
WO2010015567A3 (en) | Controlled release formulations using intelligent polymers | |
AR080736A1 (es) | Composicion farmaceutica de disolucion rapida, usualmente bucodispersable, y proceso para prepararla | |
UY32761A (es) | Preparaciones termoestables y preparaciones insulinicas estables a las vibraciones | |
CR20110599A (es) | Composiciones farmacéuticamente activas que comprenden moduladores de estrés oxidativo (osm), nuevas entidades químicas, composiciones y usos | |
AR059359A1 (es) | Formulaciones farmaceuticas que contienen pleconaril | |
CY1110037T1 (el) | Σκευασματα για βενζιμιδαζολυλ πυριδυλ αιθερες | |
AR059357A1 (es) | Formulaciones farmaceuticas | |
PE20081406A1 (es) | Composiciones farmaceuticas de flunixina | |
AR052787A1 (es) | Proceso para preparar formulaciones de sustancias activas lipofilicas mediante liofilizacion por atomizacion | |
CL2007002754A1 (es) | Composicion emulsionante de agroquimicos activos, tensoactivos, solventes aromaticos, diacetato de propilenglicol, 1,3-dimetil-2-imidazolidinona y auxiliares de formulacion; solvente para compuestos agroquimicos; dilucion que comprende la composicion | |
CL2007001981A1 (es) | Composicion que comprende al menos un principio activo agroquimico del grupo de los piretroides, al menos un tensioactivo, y al menos un disolvente no miscible en agua; procedimiento para la lucha contra las plagas animales; y su uso. | |
RS54420B1 (en) | FORMULATION CONTAINING PHENYLAMINOPYRIMIDINE DERIVATIVE AS ACTIVE INGREDIENT | |
CL2011001207A1 (es) | Extruidos que contienen al menos una sustancia farmacéuticamente activa en forma de agujas, tal que la relación entre el tamaño de partículas de la sustancia farmacéuticamente activa con forma de agujas y el diámetro de la cadena es de al menos 1:20; composición farmacéutica; y su uso para preparar medicamentos. | |
AR062626A1 (es) | Comprimidos de polimero de poliestireno sulfonato, su preparacion y uso | |
AR105503A1 (es) | Concentrado que contiene alprostadil | |
CO2017011220A2 (es) | Proceso para la fabricación de mezclas de polvo seco | |
CO6270249A2 (es) | Fibra, pelicula o espuma que comprende un plastificador y un gel ligado a arcilla cargado y metodos para su produccion | |
TH104743B (th) | ผลิตภัณฑ์แพร่กระจายแข็งที่มีสารประกอบ n-อะริล ยูเรีย |